Ralf Kuriyel, Senior VP, R&D at REPLIGEN CORP (RGEN), sold 185 shares at $59.16 ($11K) on 2019-02-28, disclosed to the SEC on 2019-03-04.
Open-market sale of $11k RGEN by Senior VP, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RGEN | SELL | 2024-03-12 | $1.4M | — | Filing → |
| RGEN | SELL | 2022-08-12 | $2.3M | — | Filing → |
| RGEN | SELL | 2021-09-02 | $2.3M | — | Filing → |